Abstract
Lanosterol is a precursor for cholesterol, which is synthesized primarily in the liver in a pathway often described as the mevalonate or HMG-CoA reductase pathway. The first two steps (formation of acetoacetyl CoA and the mitochondrial generation of (S)-3-hydroxy-3-methylglutaryl-CoA) are also associated with oxidation of fatty acids.
Cite
CITATION STYLE
APA
Benson, H. E. (2023). Lanosterol biosynthesis pathway in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). https://doi.org/10.2218/gtopdb/f104/2023.1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free